New Zealand markets closed

Rapid Dose Therapeutics Corp. (DOSE.CN)

Canadian Sec - Canadian Sec Real-time price. Currency in CAD
Add to watchlist
0.18000.0000 (0.00%)
At close: 01:17PM EDT
Currency in CAD

Valuation measures4

Market cap (intra-day) 19.16M
Enterprise value 21.75M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)17.88
Price/book (mrq)26.24
Enterprise value/revenue 20.81
Enterprise value/EBITDA -1.21

Trading information

Stock price history

Beta (5Y monthly) 0.65
52-week change 328.57%
S&P500 52-week change 322.55%
52-week high 30.2750
52-week low 30.0900
50-day moving average 30.2207
200-day moving average 30.1748

Share statistics

Avg vol (3-month) 357.68k
Avg vol (10-day) 347.01k
Shares outstanding 5106.42M
Implied shares outstanding 6106.42M
Float 894.7M
% held by insiders 19.76%
% held by institutions 10.00%
Shares short (15 May 2024) 454.49k
Short ratio (15 May 2024) 40.98
Short % of float (15 May 2024) 4N/A
Short % of shares outstanding (15 May 2024) 40.05%
Shares short (prior month 15 Apr 2024) 4481

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:5
Last split date 316 Feb 2018

Financial highlights

Fiscal year

Fiscal year ends 28 Feb 2023
Most-recent quarter (mrq)30 Nov 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-375.72%

Management effectiveness

Return on assets (ttm)-80.78%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)1.05M
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)-23.50%
Gross profit (ttm)N/A
EBITDA -2.62M
Net income avi to common (ttm)-3.56M
Diluted EPS (ttm)-0.0500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)166.18k
Total cash per share (mrq)0
Total debt (mrq)3.02M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.13
Book value per share (mrq)-0.04

Cash flow statement

Operating cash flow (ttm)-1.09M
Levered free cash flow (ttm)86.13k